EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 231 filers reported holding EDITAS MEDICINE INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $107,010 | -27.8% | 14,760 | -11.7% | 0.02% | -34.4% |
| Q4 2022 | $148,227 | -34.1% | 16,711 | -9.2% | 0.03% | -37.3% |
| Q3 2022 | $225,000 | -2.6% | 18,412 | -5.9% | 0.05% | +2.0% |
| Q2 2022 | $231,000 | -35.3% | 19,558 | +4.3% | 0.05% | -23.1% |
| Q1 2022 | $357,000 | -24.4% | 18,748 | +5.4% | 0.06% | -16.7% |
| Q4 2021 | $472,000 | -57.2% | 17,793 | -33.7% | 0.08% | -62.3% |
| Q3 2021 | $1,103,000 | -29.1% | 26,851 | -2.3% | 0.21% | -29.8% |
| Q2 2021 | $1,556,000 | +31.2% | 27,476 | -2.7% | 0.30% | +18.0% |
| Q1 2021 | $1,186,000 | +48.4% | 28,238 | +147.9% | 0.25% | +26.3% |
| Q4 2020 | $799,000 | +169.9% | 11,390 | +8.1% | 0.20% | +125.0% |
| Q3 2020 | $296,000 | -6.3% | 10,538 | -1.2% | 0.09% | -20.0% |
| Q2 2020 | $316,000 | – | 10,671 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |